Omics! Omics!

It's fall, and the foliage in New England is putting on its usual spectacular show.  What isn't showing is any of the progress in na...

Roughly speaking, NGS sample preparation workflows can be split into two basic classes of workflows.  Complete molecule workflows are curren...

An email this morning alerted me that BGI Shenzhen is acquiring Complete Genomics.  I hadn't been following Complete's business very...

A news item meant to shock its readers caught my eye, but in the end I was shocked and sickened in a way that I think lay far beyond the wri...

If you tour around the extended Kendall Square area of Cambridge, you'll find a number of large construction sites.  Various projects fo...

When I was a boy, a nearly annual occurrence was a trip to Kentucky to my maternal grandparents' house.  My biological grandmother died ...

Besides the l ittle cancer genomics piece yesterday, another genomics paper getting quite a bit of popular press attention is the nice work...

The newswires are alive with summaries of an item in Science Express which, discounting the supplementary material, isn't much bigger t...

Recently, the topic of jackalopes showed up at work.  Anyone who has toured the American West has probably come across postcards of these c...

I had a bit of a long commute yesterday, driving from south-central New Jersey up to Starbase Cambridge.  In general it's a dull ride, h...

In Nature this week (as an open access article!) is a report from Complete Genomics and collaborators describing CG's new "Long Fr...

Today's news (take your pick of Bio-IT or GenomeWeb  for original stories) is that Qiagen has bought out Intelligent Biosystems (IBS), ...

A piece of advice for anyone in the bioinformatics world: get working knowledge of the Amazon EC2 cloud computing system.  Now, there is a ...

The annual BIO meeting will be in Boston next week, so the media is looking a little bit more at our sector.  Today's Globe has an Op-Ed...

I've slipped back into a lack of posting again.  Some of it is a residual from my recovery this spring from surgery (physical therapy ca...

Tonight I will continue the recent trend of punching these out on some magical date.  Now, I usually have some sorry excuses for my erratic ...

A serious issue which has been raised often both by myself and commenters is the challenge of properly evaluating sequencer performance prio...

I've tried pretty hard to keep this blog focused on all the omics, but occasionally take the license to stray to my other interests, pri...

Last week's piece on Oxford Nanopore got a lot of attention and a lot of comments, which to me is the true mark of success in this spac...

Oxford Nanopore's AGBT presentation should have just finished up, so the embargo is off.  Oxford was kind enough to chat with me last ni...